Citation

BibTex format

@inproceedings{Doffman:2024,
author = {Doffman, S and Dosanjh, D and Sadiq, M and Asimus, S and Cooper, J and Zhou, X-H and Seth, H and Pandya, HC and Saralaya, D and Beier, J and Forsman, H and Brown, MN and Matsunaga, Y and Belvisi, MG and Molfino, NA},
publisher = {AMER THORACIC SOC},
title = {Phase 1 Safety and Efficacy of AZD8630/AMG 104 Inhaled Anti-TSLP in Healthy Volunteers and Patients With Asthma on Medium-High Dose Inhaled Corticosteroid (ICS) and Long-Acting Beta-agonist (LABA) With Elevated Baseline Fractional Exhaled Nitric Oxide (FeNO)},
year = {2024}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Doffman,S
AU  - Dosanjh,D
AU  - Sadiq,M
AU  - Asimus,S
AU  - Cooper,J
AU  - Zhou,X-H
AU  - Seth,H
AU  - Pandya,HC
AU  - Saralaya,D
AU  - Beier,J
AU  - Forsman,H
AU  - Brown,MN
AU  - Matsunaga,Y
AU  - Belvisi,MG
AU  - Molfino,NA
PB  - AMER THORACIC SOC
PY  - 2024///
SN  - 1073-449X
TI  - Phase 1 Safety and Efficacy of AZD8630/AMG 104 Inhaled Anti-TSLP in Healthy Volunteers and Patients With Asthma on Medium-High Dose Inhaled Corticosteroid (ICS) and Long-Acting Beta-agonist (LABA) With Elevated Baseline Fractional Exhaled Nitric Oxide (FeNO)
ER  -
Download